本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

15.01
-0.2600-1.70%
盤後15.100.0900+0.60%19:59 EDT
成交量:143.00萬
成交額:2,137.61萬
市值:17.89億
市盈率:-14.43
高:15.30
開:15.24
低:14.70
收:15.27
資料載入中...
2024/01/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/25

SEC問詢函

Form CORRESP - Correspondence
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/11/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/19

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/09/16

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/09/16

SEC問詢函

Form CORRESP - Correspondence
2023/09/15

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]